Dynactin p62 Inhibitors

Dynactin p62 inhibitors includes compounds that primarily target cytoskeletal dynamics, particularly microtubule and actin filament organization. These compounds exert their effects either by stabilizing or destabilizing these structures, which are crucial for intracellular transport and cellular division, processes in which Dynactin p62 plays a significant role. For instance, compounds like Paclitaxel, Nocodazole, and Vinblastine directly target microtubules, either stabilizing or destabilizing them. This can disrupt the normal function of Dynactin p62, which is essential for microtubule-dependent transport. Similarly, Colchicine and Vincristine, which interfere with microtubule polymerization, can impact the ability of Dynactin p62 to interact with and transport cargo along these cellular structures. On the other hand, compounds like Cytochalasin D, Latrunculin A, and Jasplakinolide target actin filaments. Since Dynactin p62 is also involved in processes that require actin dynamics, such as in certain types of cellular movement and division, disrupting actin filament organization can indirectly affect Dynactin p62 function. Additionally, inhibitors like Blebbistatin, Y-27632, and ML-7 target other elements of the cytoskeletal network, such as myosin and kinases involved in cytoskeletal regulation. By altering the dynamics of these components, these compounds can indirectly influence the functional roles of Dynactin p62 in cellular processes.